FDA Determines Regulatory Review Period for OCS LUNG SYSTEM Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for OCS LUNG SYSTEM, a medical device patent extension application submitted to the US Patent and Trademark Office (USPTO).